MAGE-TAB Version 1.1 Comment[MetaboBank accession] MTBKS236 Study Title Lipidome analysis of the muscles from skeletal muscle-specific GDE5 dficient mice, from denerved mice, and from Mdx mice. Study Description GDE5 is an enzyme to hydrolyze glycerophosphodiesters specially glycerophosphocholine. Skeletal muscle-specific GDE5 deficient mice showed a reduced muscle force. Lipidome analysis showed that the level of phosphatidylcholine and phosphatidylethanolamine containing linoleic acid were elebvated, and in contrast, those containing DHA and EPA were lowered in the muscles of GDE KO mice. The similar compositional change was observed in the case of the denervation and Duchenne muscular dystrophy (Mdx) mouse models. Experimental Design genetic modification design injury design Experimental Factor Name genotype treatment Experimental Factor Type genotype treatment Person Last Name Ohshima Person First Name Noriyasu Person Mid Initials Person Affiliation Gunma University Person Roles submitter PubMed ID Publication DOI Protocol Name Sample collection Extraction Chromatography Mass spectrometry Data processing Metabolite identification Protocol Type Sample collection Extraction Chromatography Mass spectrometry Data processing Metabolite identification Protocol Description Male wild-type and skeletal muscle-specific GDE5 deficient mice (15 weeks) were fed normal diet. Gastrocnemius (GAS) muscles were used for lipidome analysis. To induce atrophy to the GAS muscles, 8-weeks old male C57BL/6 mice were subjected to hindlimb denervation. Mice were anesthetized using 1.5-2% inhaled isoflurane during surgery. Approximately 5 mm section of the sciatic nerve in the right hindlimb of mice were cut, and the left hindlimb was sham-operated. Non-operated mice were used as the external control to avoid potential physiological effect of denervation on its contralateral limb. Denervated mice were dissected after the respective post-surgery period. GAS muscles of both limbs were obtained and stored for lipidome analysis. Mdx mice were provided from Jikei University School of Medicine and National Center for Neurology and Psychiatry and fed normal diet. GAS muscles were obtained from Mdx mice and stored for lipidome analysis. Mice were maintained in accordance with the Hiroshima University guidelines for the care and use of laboratory animals (Ethical approval No. C22-30). "Lipid extraction: Gastrocnemius muscles from mice were collected on ice, weighed, and transferred into a glass tube. Then, 2 ml of MeOH, 1 ml of CHCl3, 0.7 ml of H2O and 5 μl of 1 mg/ml 2-isopropylmalic acid (2-IPM) (Sigma-Aldrich) as an internal standard were added to the tube. The mixture was vortexed for 20 min at room temperature. Then, 1 ml of CHCl3 and 2 ml of water were added to the tube. The mixture was vortexed for 20 min at room temperature before centrifugation at 500×g for 10 min at room temperature. The resultant lower layer containing lipids during the extraction process was transferred to a new glass tube and was dried under nitrogen gas stream. Each lipid solution was prepared by adding a solvent mixture (CHCl3:MeOH = 2:1) which volume was set to be 1 ml/0.1 g tissue. Then, 10 μl of the lipid solution was transferred to a new glass tube and evaporated to dryness. The dried sample was dissolved in 100 μl of MeOH:toluene (9/1) containing the following internal standards, 1.5 μg/ml PE (17:0/17:0), 7.5 μg/ml PG (17:0/17:0), 1.5 μg/ml PC (17:0/0:0), 0.30 μg/ml sphingosine (d17:1), 0.75 μg /ml ceramide (d18:1/17:0), 0.60 μg/ml SM (d18:1/17:0), 3 μg/ml palmitic acid-D3, 0.40 μg/ml PC (12:0/13:0), 30 μg/ml cholesterol-D7, 0.30 μg/ml TAG (17:0/17:1/17:0), 3.0 μg/ml DAG (12:0/12:0/0:0), 1.5 μg/ml DAG (18:1/2:0/0:0), 6.0 μg/ml MAG (17:0/0:0/0:0), 0.75 μg/ml PE (17:1/0:0), 15 μg/ml cholesteryl ester (22:1), and 75 ng/ml CUDA (12-[[(cyclohexylamino)carbonyl]amino]-dodecanoic acid. Each sample was sonicated for 30 sec and vortexed for 10 sec at room temperature. The solution was transferred to a glass vial with micro-insert." Column chromatography: LC-MS measurement was performed on a LC system, Nexera X2 (Shimadzu) and TripleTOF 6600 equipped with a DuoSpray ion source (Sciex). The injection volumes are 3 μL in positive mode and 5 μL in negative mode. The order of the samples was randomized. The flow rate was 0.6 mL/min, and the temperature of the column oven was kept at 65 °C. The autosampler temperature was 4 °C. Mobile phase A was 60:40 acetonitrile:water (v/v) containing 10 mM ammonium formate and 0.1% formic acid. Mobile phase B was 90:10 isopropanol:acetonitrile (v/v) containing 10 mM ammonium formate and 0.1% formic acid. The LC method used an Acquity UPLC CSH C18 column (100 × 2.1 mm; 1.7 μm) connected to an Acquity CSH C18 VanGuard pre-column (5 × 2.1 mm; 1.7 μm) (Waters; Milford, MA, USA). The gradient was 0 min, 15% B; 2 min, 30% B; 2.5 min, 48% B; 11 min, 82% B, 11.5 min, 99% B; 12 min, 99% B; 12.1 min, 15% B; 15 min, 15% B. "Mass spectrometry: MS measurement was performed on TripleTOF 6600 equipped with a DuoSpray ion source (Sciex). Measurements were performed at the high sensitivity mode for both TOF MS and product ion scan. The mass calibration was automatically performed every 6 injections via a calibration delivery system using an APCI positive/negative calibration solution. SWATH (sequential window acquisition of all theoretical mass spectra) acquisition for negative ion mode was used to achieve data independent acquisition. The mass range of the MS1 and MS2 was set at m/z 100-1250 and 200-1250, respectively. The scan duration of MS1 and MS2 was 50 msec and 10 msec, respectively. The SWATH window is set at 21 Da. Other parameters were collision energy, 45 V; collision energy spread, 15 V; curtain gas, 35 psi; ion source gas 1, 60 psi; ion source gas 2, 60 psi; temperature, 350 °C; declustering potential, 80 V; ion spray voltage, -4500 V. Data acquisition: Analyst TF 1.8 (SCIEX) was used for data acquisition and processing. Data transformation: Analysis Base File Converter (Abf converter) (Reifycs) was used for transformation the the acquired .wiff and .wiff.scan file to the .abf file." data not submitted data not submitted Protocol Parameters Post extraction;Derivatization Chromatography instrument;Autosampler model;Column model;Column type;Guard column Scan polarity;Scan m/z range;Instrument;Ion source;Mass analyzer Protocol Hardware Protocol Software Public Release Date 2024-05-07 Term Source Name Term Source File Term Source Version SDRF File MTBKS236.sdrf.txt Comment[Study type] lipid profiling Comment[Experiment type] liquid chromatography-mass spectrometry Comment[Submission type] LC-MS Comment[BioProject] PRJDB17952 Comment[Related study] Comment[Contributor] Comment[Submission Date] 2024-04-28 Comment[Last Update Date] 2024-05-07